Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Behniya Azadmehr"'
Autor:
Nazila Yousefi, Behniya Azadmehr, Seyyed Ali Hashemi, Mohammadhossein Motevali Khameneh, Farzad Peiravian
Publikováno v:
Rāhburdhā-yi Mudīriyyat dar Niẓām-i Salāmat, Vol 8, Iss 2, Pp 161-175 (2023)
Background: Biosimilars can be considered generic versions of branded biologic medicines. Substituting branded biologic medicines with biosimilars is important to reduce medication costs. In addition to reducing drug costs, the domestic production of
Externí odkaz:
https://doaj.org/article/0a55eac738a1459096e3513bd22835e8
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 20, Iss 1, Pp 1-14 (2022)
Abstract Objectives This study was aimed to systematically review published economic studies to determine whether dapagliflozin, a sodium-glucose co-transporter inhibitor, plus standard care therapy (SCT) is cost-effective in heart failure with reduc
Externí odkaz:
https://doaj.org/article/545a6e09cfcc4cedba140878530e47c2
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 22:1187-1198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76cbcd92ae42c061291b5515f8e0a7d5
https://doi.org/10.1080/14737167.2022.2130761
https://doi.org/10.1080/14737167.2022.2130761
Autor:
Mohammadnezhad, Ghader, Ehdaivand, Sadaf, Sebty, Mehrshad, Azadmehr, Behniya, Ziaie, Shadi, Esmaily, Hadi
Publikováno v:
BMC Nephrology; 12/18/2024, Vol. 25 Issue 1, p1-9, 9p
Autor:
Mohammadnezhad, Ghader1 (AUTHOR), Azadmehr, Behniya1 (AUTHOR), Mirheidari, Mehdi1 (AUTHOR), Yousefi, Nazila2 (AUTHOR) n.yousefi@sbmu.ac.ir
Publikováno v:
Cost Effectiveness & Resource Allocation. 12/1/2022, Vol. 20 Issue 1, p1-14. 14p.
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research; Dec2022, Vol. 22 Issue 8, p1187-1198, 12p
Publikováno v:
Drug Week; 10/20/2023, p2431-2431, 1p